I discovered a new Web site called Healing Innovation; more on that later.  A recent post on that site addressed the importance of early and frequent clinical studies in a very convincing manner.  One's first reaction is likely to be:  "I can barely afford one trial, how can I possibly afford many?"  But the author makes a strong case for early, small pilot and feasibility studies for purposes of design and procedural improvements prior to a definitive clinical trial (if such a trial is required at all).  This post will cause you to think beyond regulatory requirements as a reason for explorations in the clinic.

     A recent article in the Boston Globe describes the products and business of a small Massachusetts company (Chamberlain Group) that provides simulated body parts to medical schools and device makers for surgical training and surgical-tool testing.  These silicone parts are replicas apparently quite good enough for training medical students and residents at some name-brand schools.  Some leading suppliers - including Boston Scientific and J&J - use these squishy models in large numbers for various purposes.  (Chamberlain has grown to 20 employees and acquired some rather fancy 3D printers and design software since 1999.)

     I find the prospect of using models such as these for uses beyond surgeon training intriguing.  Consider product demos to support sales efforts.  Or body-part simulators for proof-of-concept studies.  Or employee training aids.  Or realistic investor pitches (maybe not!).